
GK Daily Special Edition: Two Shots a Year, Zero Infections — Inside the Global Race to Share Yeztugo
Picture a clinical trial where more than 2,000 young women were given a shot every six months, and at the end of it, not one of them caught HIV. Zero. That actually happened, and the drug behind it is now approved in the United States under the brand name Yeztugo. But the story of what happened after that trial result landed is just as dramatic as the science itself, full of diplomatic standoffs, pricing fights, and a race against time in the countries that need it most.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.